Background: Newborns with hypoplastic left heart syndrome (HLHS) or right heart syndrome or other malformations with a single ventricle physiology and associated hypoplasia of the great arteries continue to be a challenge in terms of survival. The vast majority of these forms of congenital heart defects relate to abnormal morphogenesis during early intrauterine development and can be diagnosed accurately by fetal echocardiography. Early knowledge of these conditions not only permits a better understanding of the progression of these malformations but encourages some researchers to explore new minimally invasive therapeutic options with a view to early pre-and postnatal cardiac palliation.
Introduction
Heart defects are among the most common congenital malformations and the reported incidence is 0.5%-1% for all neonates. About half of these cardiovascular malformations are severe and usually require one or more surgical procedures in the neonatal period or during childhood. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] In Switzerland, every pregnant woman is entitled to two routine ultrasound scans by her obstetrician as part of routine prenatal care. [11] [12] [13] Besides determining fetal growth and the development of pregnancy, the function of the second and increasingly of the fi rst scan is to identify malformations in the fetus. [14] [15] [16] [17] [18] [19] However, international and national prospective studies of prenatal "screening for heart defects" show that, up to now only 10%-30% of all cardiac defects or 20%-50% of discoverable cardiac lesions using the "four-chamber" ultrasound screening are actually diagnosed prenatally. [10, If the neonatal mortality fi gures are considered in detail, it is striking that about 20% of all infant deaths and therefore 50% of these deaths can still be attributed to congenital heart disease or cardiovascular malformations. [11, 18, 19, 33, 34, 39, 40] Interdisciplinary collaboration between neonatology, obstetric and prenatal medicine, pediatric cardiology, pediatric cardiac surgery and human genetics is essential to improve the baseline for perinatal treatment of these neonates, who are Prenatal diagnosis and treatment planning of congenital heart defects Review article sometimes born seriously ill. If a heart defect has already been diagnosed prenatally, the infant with heart disease can usually be born spontaneously in the relevant perinatal or cardiac pediatric center and be treated and cared for without delay in the affi liated departments, thus avoiding a potentially hazardous postnatal transport. In many cases early interventional and/or surgical treatment is important for improving the prognosis of the neonate with heart disease besides using intensive care and medication. [10, 11, [18] [19] [20] 23, 27, 35, 36] Several large studies have confi rmed that not only perinatal management but also mortality and postoperative morbidity of affected newborns are markedly improved by the prenatal discovery of a transposition of the great vessels or hypoplastic left heart syndrome for example. [3, 9, 18, 19, [40] [41] [42] [43] [44] [45] Moreover, it is increasingly postulated that the postnatal treatment of cardiac malformations diagnosed in utero is delayed because morphological causes of these conditions (e.g., valve stenosis or dysplasia) can lead to, sometimes irreversible, secondary damage to sections of the heart and vessels without a primary malformation because intracardiac and intravascular hemodynamics are altered during the course of fetal growth compared to extra-uterine conditions. [4, 6, 12, 13, 18, 19, [25] [26] [27] 30, 37, 45] It is evident that these ideas about the genesis and prenatal progression of congenital heart malformations will have a crucial infl uence on future treatment plans. Discussion of possible developments in the next few years in the area of intrauterine treatment of certain obstructive heart defects may appear speculative at present. [4] [5] [6] 12, 13, 18, 19, [25] [26] [27] 30, 37, 45, 46] Nevertheless, this article presents an early compressed and critical picture not only of current prenatal diagnostic and counselling possibilities but also of the fi rst in utero case histories.
Indications and limitations of prenatal cardiac diagnosis
The problem of referral for specialized fetal echocardiography to screen for or confi rm the diagnosis of congenital heart malformations is closely linked to the recognition of possible risk factors. In only about 10%-30% of fetuses with cardiac lesions, there are case-history related or (molecular) genetic risks (family history, teratogens in early pregnancy, maternal disease, new mutations detectable by molecular genetics). [16, 18, 19, 21, 22, 32, 34, 35, 37] Since a risk factor can currently not be elicited either from the history or with conventional genetic or molecular genetic methods in 70%-90% of congenital heart defects, sonographic "abnormalities" on obstetric ultrasound screening during prenatal care point the way to effective use of the expertise available in pre-and perinatal centers. About 40%-50% of congenital heart defects can be discovered with just the four-chamber view in a lowrisk population, and additional examination of the outfl ow tracts and the two great arteries increases this rate to 65%-70% and encompasses all critical cardiac defects. [17] [18] [19] [20] 33, 34, 36, 37] However, this potential is currently by no means reached. In surveys of diagnosed malformations, congenital heart defects are markedly underrepresented compared with malformations of other organs, as they usually elude prenatal diagnosis. [10, 11, [16] [17] [18] [19] [20] 24, 28, 33, 36, 38, 40, 47, 48] This may be due to interpretation of the scans of the heart taken from various angles, which demands good spatial awareness on the part of the examiner, and the assessment of even an optimal four-chamber view is highly dependent on the examiner's level of training. Diagnostic imaging of the fetal heart, as in all ultrasound imaging, depends greatly on the structure and extent of the overlying layers of maternal and fetal tissues. It is crucially important to record all malformations prenatally as exactly as possible, particularly in fetuses in which additional extracardiac malformations are found during prenatal investigations. If co-existing chromosome abnormalities are found, further stressful diagnostic measures or measures to prolong the pregnancy can be omitted because of the associated and sometimes substantial worsening of the fetal prognosis.
A growing group of patients who should be referred for more intensive prenatal diagnosis consists of those who deliberately forego chromosome testing (e.g., by amniocentesis or chorionic villus biopsy) because of the low risk of abortion despite the presence of an indication. Precisely in this group, defi nite ultrasonic exclusion of a fetal cardiac lesion is more important since a heart defect is present in approximately 50% of neonates with trisomy 21, approximately 99% with trisomy 18, approximately 90% with trisomy 13 and in 35% of fetuses with Noonan's syndrome. [18, 19, [20] [21] [22] 28, 33, 34, 40] There have been only a few studies from German-speaking countries investigating the extent to which fetuses with congenital heart defects were actually detected in the course of general prenatal care and referred to a perinatal/pediatric cardiology center for further investigation, counselling and treatment planning. [23, 24, 40] The authors were entirely justifi ed in concluding from their sobering results, showing, for instance, only a 10% prenatal detection rate for congenital right heart defects, that crucial progress would be achievable only by a marked improvement in both the level of training and the technical equipment of all involved in prenatal screening for malformations. The fact that the tentative external diagnosis of a possible heart defect can be confi rmed in most fetuses investigated in regional World Journal of Pediatrics
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prenatal medical centers emphasizes the importance of primary detection during prenatal care. [18] [19] [20] 23, 24, 33, 35, 36] In principle, the majority of congenital heart defects can already be diagnosed by prenatal echocardiography and the detection rate is 85%-95% at tertiary perinatal centers. [9] [10] [11] [16] [17] [18] [19] [20] 23, 24, 35, 36, 44] Nevertheless, in a few cases, exact and complete diagnosis is only successful postpartum as all current methods of intrauterine imaging of cardiac defects have numerous limitations including susceptibility to interference from fetal movements and marked dependence on fetal position. Segments of the heart overlaid by bony fetal thorax, spine or limb structures or parts of the heart situated posteriorly with oligo-or anhydramnios cannot be imaged especially at an advanced stage of pregnancy because of the absence of "fetal acoustic window". A further limitation is suboptimal or incomplete imaging of fetal heart segments with an extensive maternal stand-off distance or unfavorable placental or amniotic fl uid conditions (e.g., deep intrauterine or deep intraabdominal fetal position).
Physicians specializing in pre-and perinatal medicine, neonatology, pediatric cardiology and pediatric cardiac surgery are confronted almost daily in their clinical practice with lack of clarity in prenatal cardiac diagnosis. Despite all these longfamiliar limitations, early prenatal detection of heart defects makes a crucial contribution to optimizing prenatal and perinatal management. It involves detailed interdisciplinary counselling of the parents, possibly prenatal chromosome testing, ultrasound exclusion of extracardiac malformations, selection of the place and time of delivery in a perinatal or pediatric cardiology center and the ensurance of immediate interventions for critical heart lesions. Prenatal establishment of a cardiac defect on its own without pediatric cardiological/pediatric cardiac surgical counselling about all aspects of pre-and postnatal prognosis and treatment options not only leads to considerable anxiety for the parents but also may jeopardize the continuation of pregnancy in individual cases.
In utero progression of congenital heart defects
Postnatal pediatric cardiology studies have shown that only a few heart defects improve or heal spontaneously over time without intervention (e.g., spontaneous closure of muscular ventricular septal defects). In contrast, the majority of complex congenital lesions show a steadily progressive course including subsequent secondary phenomena such as arrhythmias or myocardial insuffi ciency. With valve stenosis/atresia diagnosed early, an increase in ventricular remodelling (sometimes irreversible endo-and/or myocardial secondary damage of the fetal heart) is often already apparent in utero. Moreover, the reduction in blood fl ow because of high-grade valve stenosis/atresia in the vascular bed downstream leads to diminished and often asymmetrical vessel growth with secondary (congenital) vessel hypoplasia. Since the early days of prenatal echocardiography diagnosis, innumerable reports have been published about intrauterine progression and increased abortion and stillbirth rates in fetuses with heart defects. [2, 5, 6, 18, 25, 27, 30, 32, 37, 45, 46] In the postnatal pediatric cardiological/pediatric cardiac surgery, it would be crucially important in the prenatal situation not only to diagnose cardiac defects as early as possible but also to treat them, thus avoiding secondary irreversible organ damage. [46] However, the corresponding cardiac structures of the fetus are accessible to many diagnostic and therapeutic procedures only at a more advanced gestational age (after the 18th week of pregnancy). With most cardiac defects, however, the organ damage is already considerable at the time of prenatal diagnosis and can no longer be corrected even by an intrauterine procedure.
Minimally invasive fetal therapy
Prenatal treatment of an abnormal fetus is an area of perinatal medicine that is undergoing a very dynamic development. Because of the rapid miniaturization of many endoscopes and cannula systems, an increasing number of fetal diseases that progress in utero are becoming accessible to prenatal treatment. [1, 7, 27, 30, 31, 37, 39, 43, [45] [46] [47] [48] For instance, with the aid of fetoscopically monitored laser coagulation, it is possible to interrupt communicating vascular anastomoses in the placenta in twin-to-twin transfusion syndrome. [7, 33, 47, 48] Experience with more extensive fetoscopic procedures on the fetus such as temporary in utero palliation of diaphragmatic hernias, myelomeningoceles or distal urinary tract obstruction is currently limited to a few centers in the world. The sometimes much milder secondary damage reported in these fetuses sounds hopeful although these experimental methods have not become part of routine care to date because of lack of long-term results with regard to comprehensive postnatal pediatric surgical/ pediatric urological/neurosurgical expertise. [1, 15, 33, 39, 47, 48] In keeping with the "early correction" aims of modern postnatal pediatric cardiac surgery, a few prenatal cardiac interventions were even performed on human fetuses. [6, 14, 18, 19, 27, 37, 45] Up to now, ultrasound-guided transabdominal or transthoracic puncture of the fetal heart in order to introduce a dilating catheter, which was then advanced into the stenotic valve, has been predominantly favored. Of the fi rst 13 fetuses with so-called critical aortic valve stenosis, in whom Prenatal diagnosis and treatment planning of congenital heart defects Review article such an intrauterine intervention was performed and analysed worldwide, only 1 fetus has survived a longterm. [28, 29, 37, 39] More recent follow-up studies, some still ongoing, appear to show a higher success and a higher survival rate. [6, 27, 45] 
Unanswered questions
Apart from the technical diffi culties, a series of questions must be discussed in connection with the optimal outcome in fetuses with heart defects that are progressive while still in utero. The natural course of heart defects detected in utero requires further intensive study as stabilization or lack of progression in the prenatal situation can be described for some of these defects with modifi ed outcome analysis so that caution is warranted with any intrauterine procedures that might cause premature birth compared to the lower-risk postnatal operations. [5, 6, [12] [13] [14] [25] [26] [27] 30, 32, 37, 42, 45, 46, 48] The possibly favorable prognostic infl uence on the patients of bringing forward the timing of these techniques must be confi rmed in the next few years by well-designed studies. Fetuses with pulmonary valve atresia and postpartum catheter intervention can demonstrate a marked increase in right-ventricular dimensions including the possibility of biventricular palliation. Careful and suffi ciently long pre-and postnatal documentation of individual cases together with collection and analysis of data in international registers is crucial. It is only by coordinating the efforts of selected national and international centers that scientifi cally confi rmed progress in this area of interventional perinatal medicine can be expected.
Conclusion
In the not too distant future, the earlier interventions presented in this review article will supplement the known conventional postnatal treatment modalities available for a few of the cardiac defects that follow a progressive prenatal course. For physicians working in the area of pre-and perinatal medicine, it will therefore become increasingly diffi cult in the coming next years to give correct advice on procedures when these pregnant women are referred to them. To assist in decision-making, evaluation studies must urgently be initiated in centers specializing in the diagnosis and treatment of infants with heart disease. However, there is a particular requirement for the interdisciplinary counselling and psychological support of parents before, during and after the treatment. Comprehensive information about the nature of the disease and the probable prognosis depending on the time of treatment including all intervention-related risks must be provided by a consortium of prenatal physicians, pediatric cardiologists and cardiac surgeons. Otherwise, scientifi c medicine would be open to the reproach that it is further infl ating the interdisciplinary diagnosis and treatment apparatus without suffi ciently validating it or making it patient-oriented.
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